We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
-11.65%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$13B
AUM Growth
-$835M
Cap. Flow
+$1.04B
Cap. Flow %
7.95%
Top 10 Hldgs %
17.44%
Holding
2,478
New
199
Increased
850
Reduced
902
Closed
277

Sector Composition

Rank Sector Weight
1 Technology 10.06%
2 Healthcare 9.47%
3 Financials 8.84%
4 Energy 7.17%
5 Industrials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCIC
2026
BCP Investment Corp
BCIC
$86.9M
$51K ﹤0.01%
1,503
RUN icon
2027
Sunrun
RUN
$2.37B
$51K ﹤0.01%
4,710
-3,330
-41% -$42.1K
PARA
2028
CALL
DELISTED
Paramount Global Class B
PARA
$49K ﹤0.01%
18,000
SQQQ icon
2029
ProShares UltraPro Short QQQ
SQQQ
$2.21B
$49K ﹤0.01%
1
-4
-80% -$145K
CRMD icon
2030
CorMedix
CRMD
$617M
$48K ﹤0.01%
7,438
-2,200
-23% -$14.7K
SRGA
2031
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$48K ﹤0.01%
431
LSTR icon
2032
CALL
Landstar System
LSTR
$6.8B
$47K ﹤0.01%
34,500
SMRT
2033
DELISTED
Stein Mart Inc
SMRT
$47K ﹤0.01%
41,000
-1,900
-4% -$3.26K
AMD icon
2034
CALL
Advanced Micro Devices
AMD
$851B
$46K ﹤0.01%
31,000
GILD icon
2035
CALL
Gilead Sciences
GILD
$161B
$46K ﹤0.01%
16,000
VTGN icon
2036
VistaGen Therapeutics
VTGN
$9.29M
$46K ﹤0.01%
1,043
+252
+32% +$13.7K
ASXC
2037
DELISTED
Asensus Surgical, Inc.
ASXC
$46K ﹤0.01%
1,592
-310
-16% -$14.1K
MCHX icon
2038
Marchex
MCHX
$79.7M
$45K ﹤0.01%
17,000
WHWK
2039
Whitehawk Therapeutics
WHWK
$183M
$43K ﹤0.01%
1,697
+834
+97% +$26.6K
VRDN icon
2040
Viridian Therapeutics
VRDN
$2.13B
$42K ﹤0.01%
915
-330
-27% -$19.1K
ARAY icon
2041
Accuray
ARAY
$28.4M
$41K ﹤0.01%
+12,000
New +$48.7K
BHC icon
2042
PUT
Bausch Health
BHC
$1.65B
$40K ﹤0.01%
44,200
LBY
2043
DELISTED
Libbey, Inc.
LBY
$40K ﹤0.01%
10,456
BCLI
2044
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$39K ﹤0.01%
718
UNH icon
2045
PUT
UnitedHealth
UNH
$382B
$39K ﹤0.01%
14,300
IWO icon
2046
PUT
iShares Russell 2000 Growth ETF
IWO
$14.5B
$38K ﹤0.01%
37,500
HEPA
2047
DELISTED
Hepion Pharmaceuticals
HEPA
$37K ﹤0.01%
2
IMGN
2048
DELISTED
Immunogen Inc
IMGN
$37K ﹤0.01%
+10,288
New +$62.4K
CSCO icon
2049
CALL
Cisco
CSCO
$450B
$35K ﹤0.01%
35,000
EXK
2050
Endeavour Silver
EXK
$2.32B
$34K ﹤0.01%
15,200
-20,500
-57% -$43K

Similar funds

HighTower Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, HighTower Advisors held 2,478 positions worth $13B, down 6% from $13.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

HighTower Advisors deployed $1.04B of net new capital in Q4 2018, opening 199 new positions and adding to 850 existing holdings. Its largest new stake was Invesco Large Cap Value ETF: 575,329 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Schwab International Equity ETF, an estimated $41.4M trimmed.

  • HighTower Advisors's largest Q4 2018 buy was Invesco Large Cap Value ETF: 575,329 shares worth $18.8M.
  • HighTower Advisors added most to ExxonMobil in Q4 2018, an estimated $325M increase.
  • HighTower Advisors's biggest Q4 2018 reduction was Schwab International Equity ETF, cutting an estimated $41.4M.
  • HighTower Advisors fully exited State Street SPDR S&P Pharmaceuticals ETF in Q4 2018, selling an estimated $15.9M.
  • HighTower Advisors's ten largest holdings make up 17% of its $13B portfolio in Q4 2018.
  • HighTower Advisors opened 199 new positions and closed 277 in Q4 2018.
  • HighTower Advisors's portfolio value fell 6% quarter-over-quarter to $13B.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.